Clinical Trial Update: A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn

View source ↗

Summary

A ClinicalTrials.gov update notes a completed study characterizing the clinical course of pregnant women and high-risk infants for early onset severe hemolytic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythroblastosis Fetalis
• Hemolytic Disease of the Fetus and Newborn

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN), Erythroblastosis, Fetal | Status: COMPLETED